Bryan WW - Search Results

1

A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients.

Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, Myers D, Heberlin L, King R, Smith J, Gelinas D, Miller RG. Jackson CE, et al. Among authors: bryan ww. J Neurol Sci. 2001 Oct 15;191(1-2):75-8. doi: 10.1016/s0022-510x(01)00617-7. J Neurol Sci. 2001. PMID: 11676995 Clinical Trial.

2

A placebo-controlled trial of gabapentin in spinal muscular atrophy.

Miller RG, Moore DH, Dronsky V, Bradley W, Barohn R, Bryan W, Prior TW, Gelinas DF, Iannaccone S, Kissel J, Leshner R, Mendell J, Mendoza M, Russman B, Samaha F, Smith S; SMA Study Group. Miller RG, et al. J Neurol Sci. 2001 Oct 15;191(1-2):127-31. doi: 10.1016/s0022-510x(01)00632-3. J Neurol Sci. 2001. PMID: 11677003 Clinical Trial.

3

A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group.

McGuire D, Garrison L, Armon C, Barohn RJ, Bryan WW, Miller R, Parry GJ, Petajan JH, Ross MA. McGuire D, et al. Among authors: bryan ww. J Neurol Sci. 1997 Oct;152 Suppl 1:S18-22. doi: 10.1016/s0022-510x(97)00239-6. J Neurol Sci. 1997. PMID: 9419049

4

Amyotrophic lateral sclerosis.

Jackson CE, Bryan WW. Jackson CE, et al. Among authors: bryan ww. Semin Neurol. 1998;18(1):27-39. doi: 10.1055/s-2008-1040859. Semin Neurol. 1998. PMID: 9562665 Review.

5

Primary hyperparathyroidism and ALS: is there a relation?

Jackson CE, Amato AA, Bryan WW, Wolfe GI, Sakhaee K, Barohn RJ. Jackson CE, et al. Among authors: bryan ww. Neurology. 1998 Jun;50(6):1795-9. doi: 10.1212/wnl.50.6.1795. Neurology. 1998. PMID: 9633730

6

Can we eliminate placebo in ALS clinical trials?

Bryan WW, Hoagland RJ, Murphy J, Armon C, Barohn RJ, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA, Stromatt SC; rhCNTF ALS Study Group. Bryan WW, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr;4(1):11-5. doi: 10.1080/14660820310006661. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 12745612 Clinical Trial.

7

Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group.

McGuire D, Garrison L, Armon C, Barohn R, Bryan W, Miller R, Parry G, Petajan J, Ross M. McGuire D, et al. Neurology. 1996 May;46(5):1442-4. doi: 10.1212/wnl.46.5.1442. Neurology. 1996. PMID: 8628496

8

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group.

Miller RG, Moore D, Young LA, Armon C, Barohn RJ, Bromberg MB, Bryan WW, Gelinas DF, Mendoza MC, Neville HE, Parry GJ, Petajan JH, Ravits JM, Ringel SP, Ross MA. Miller RG, et al. Among authors: bryan ww. Neurology. 1996 Dec;47(6):1383-8. doi: 10.1212/wnl.47.6.1383. Neurology. 1996. PMID: 8960715 Clinical Trial.

9

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.

Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SC. Miller RG, et al. Among authors: bryan ww. Ann Neurol. 1996 Feb;39(2):256-60. doi: 10.1002/ana.410390215. Ann Neurol. 1996. PMID: 8967757 Clinical Trial.

10

Electrophysiologic findings in multifocal motor neuropathy.

Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ. Katz JS, et al. Among authors: bryan ww. Neurology. 1997 Mar;48(3):700-7. doi: 10.1212/wnl.48.3.700. Neurology. 1997. PMID: 9065551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page